Cerebain Biotech Moves Up To Beat Record of 2021

What a nice 2021’s January is aiding Cerebain Biotech (CBBT) to climb over the $0.01 tag initially so later it could cross the $1 barrier easily.

Cerebain Biotech Moves Up To Beat Record of 2021

In December 2020 CBBT shares just amazed so many traders by rocketing from $0.0195 to as high as $0.0818 on an average volume of 31 million units. For such a cheap stock the drastic growth was simple due to the announcing of ClearMask (face mask for COVID-19) manufacturing will belong to PKG which will fully become a subsidiary of Cerebain soon.

In January, CCBT is making significant attempts to surpass $0.08 despite volatility during uncertain times in the OTC market which has so many beaten-up stocks of past years and even decades. Hopefully, Cerebain may return to one of the national exchanges of the U.S after a successful boost in revenue and earnings.

Cerebain Biotech Moves Up To Beat Record of 2021

Alex Krakowsky

Editor in Chief.Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life